RT Journal Article
SR Electronic
T1 Effect of storage conditions on SARS-CoV-2 RNA quantification in wastewater solids
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.04.21256611
DO 10.1101/2021.05.04.21256611
A1 Adrian Simpson
A1 Aaron Topol
A1 Bradley White
A1 Marlene K. Wolfe
A1 Krista Wigginton
A1 Alexandria B. Boehm
YR 2021
UL http://medrxiv.org/content/early/2021/05/08/2021.05.04.21256611.abstract
AB SARS-CoV-2 RNA in wastewater settled solids is associated with COVID-19 incidence in sewersheds and therefore, there is a strong interest in using these measurements to augment traditional disease surveillance methods. A wastewater surveillance program should provide rapid turn around for sample measurements (ideally within 24 hours), but storage of samples is necessary for a variety of reasons including biobanking. Here we investigate how storage of wastewater solids at 4°C, -20°C, and -80°C affects measured concentrations of SARS-CoV-2 RNA. We find that short term (7-8 d) storage of raw solids at 4°C has little effect on measured concentrations of SARS-CoV-2 RNA, whereas longer term storage at 4°C (35-122 d) or freezing reduces measurements by 60%, on average. We show that normalizing SARS-CoV-2 RNA concentrations by concentrations of pepper mild mottle virus (PMMoV) RNA, an endogenous wastewater virus, can correct for changes during storage as storage can have a similar effect on PMMoV RNA as on SARS-CoV-2 RNA. The reductions in SARS-CoV-2 RNA in solids during freeze thaws is less than those reported for the same target in liquid influent by several authors.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis paper is not a clinical trial.Clinical Protocols https://www.protocols.io/view/high-throughput-pre-analytical-processing-of-waste-btyqnpvw https://www.protocols.io/view/high-throughput-rna-extraction-and-pcr-inhibitor-r-btyrnpv6 https://www.protocols.io/view/high-throughput-sars-cov-2-pmmov-and-bcov-quantifi-btywnpxe Funding StatementThis study was funded by the CDC-Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is not a human subjects study. No human subjects participated in this research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available from Stanford Digital Repository at the link provided in the paper. https://purl.stanford.edu/yn042kx5009